Latest Patrys (ASX:PAB) News

Page 3

Page 3 of 3

Patrys Advances PAT-DX3 Amid Cash Pressures and Strategic Licensing Moves

Patrys Pushes PAT-DX3 Forward Amid Cash Constraints and Strategic Shifts

Patrys Limited advances its PAT-DX3 therapy development for inflammatory diseases while navigating cash flow challenges and pursuing partnerships to sustain operations.

Ada Torres

30 Apr 2025

Patrys Abandons PAT-DX1 Trial Plans, Accelerates PAT-DX3 Development

Patrys Shifts Focus to PAT-DX3 After PAT-DX1 Fails Clinical Readiness

Patrys Limited has halted plans for a Phase 1 trial of PAT-DX1 following disappointing GMP production results, pivoting its development efforts towards PAT-DX3 and exploring new partnerships.

Ada Torres

30 Jan 2025